Edmonton, Canada

Larry Guilbert

This inventor holds 1 USPTO granted patent. Top assignee: Fx Lifesciences Ag. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Larry Guilbert. Retrieved from https://idiyas.com/inventor/larry-guilbert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Larry Guilbert: Pioneering Autoimmune Disease Treatment

Introduction: Larry Guilbert, an inventor based in Edmonton, Canada, has made notable contributions to the field of pharmaceuticals. His innovative work focuses on using American ginseng extracts for the treatment of autoimmune diseases, showcasing the potential of natural products in modern medicine.

Latest Patents: Larry Guilbert holds a patent for the treatment of autoimmune diseases using American ginseng extract. His patent, which encompasses the use of specific ginseng extracts designated CVT-E002, PQ, PQA, PQB, PQC, PQD, and PQ, involves the preparation of a pharmaceutical composition suitable for tackling autoimmune conditions. This innovative approach offers a promising avenue for addressing complex medical challenges.

Career Highlights: Larry is currently employed at Fx Lifesciences AG, where he utilizes his expertise to advance research in therapeutic solutions. His dedication to developing effective treatments underlines his commitment to enhancing patient care through innovation.

Collaborations: Throughout his career, Larry has collaborated with esteemed colleagues, including Jacqueline J. Shan and Joanne Totosy De Zepetnek. Their combined efforts contribute to a dynamic research environment focused on discovering novel treatments and improving health outcomes.

Conclusion: Larry Guilbert stands out as a valuable inventor in the realm of autoimmune disease treatment. Through his patent for using American ginseng extracts, he exemplifies the intersection of traditional medicine and modern scientific inquiry. With ongoing collaborations and a commitment to innovation, Larry continues to push the boundaries of pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…